These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 19705995)

  • 1. Recent patents on novel P2X(7) receptor antagonists and their potential for reducing central nervous system inflammation.
    Friedle SA; Curet MA; Watters JJ
    Recent Pat CNS Drug Discov; 2010 Jan; 5(1):35-45. PubMed ID: 19705995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complexities of measuring antagonist potency at P2X(7) receptor orthologs.
    Hibell AD; Thompson KM; Xing M; Humphrey PP; Michel AD
    J Pharmacol Exp Ther; 2001 Mar; 296(3):947-57. PubMed ID: 11181928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of P2X7 receptor-selective antagonists offers new insights into P2X7 receptor function and indicates a role in chronic pain states.
    Donnelly-Roberts DL; Jarvis MF
    Br J Pharmacol; 2007 Jul; 151(5):571-9. PubMed ID: 17471177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of P2X7 receptor in glial and neuroblastoma cells: the therapeutic potential of P2X7 receptor antagonists.
    Sun SH
    Mol Neurobiol; 2010 Jun; 41(2-3):351-5. PubMed ID: 20405342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissecting individual current components of co-expressed human P2X1 and P2X7 receptors.
    Seyffert C; Schmalzing G; Markwardt F
    Curr Top Med Chem; 2004; 4(16):1719-30. PubMed ID: 15579104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular nucleotides differentially regulate interleukin-1beta signaling in primary human astrocytes: implications for inflammatory gene expression.
    John GR; Simpson JE; Woodroofe MN; Lee SC; Brosnan CF
    J Neurosci; 2001 Jun; 21(12):4134-42. PubMed ID: 11404398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidized ATP decreases beta-actin expression and intracellular superoxide concentrations in RBA-2 type-2 astrocytes independently of P2X7 receptor.
    Chen HB; Lin YH; Sun SH
    Eur J Pharmacol; 2006 Nov; 550(1-3):1-7. PubMed ID: 17020759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid ATP-induced release of matrix metalloproteinase 9 is mediated by the P2X7 receptor.
    Gu BJ; Wiley JS
    Blood; 2006 Jun; 107(12):4946-53. PubMed ID: 16514055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of cultured dorsal root ganglion neuron P2X receptors.
    Grubb BD; Evans RJ
    Eur J Neurosci; 1999 Jan; 11(1):149-54. PubMed ID: 9987019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purinergic signalling in brain ischemia.
    Pedata F; Dettori I; Coppi E; Melani A; Fusco I; Corradetti R; Pugliese AM
    Neuropharmacology; 2016 May; 104():105-30. PubMed ID: 26581499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purinergic signaling in kidney disease.
    Menzies RI; Tam FW; Unwin RJ; Bailey MA
    Kidney Int; 2017 Feb; 91(2):315-323. PubMed ID: 27780585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity relationships of suramin and pyridoxal-5'-phosphate derivatives as P2 receptor antagonists.
    Lambrecht G; Braun K; Damer M; Ganso M; Hildebrandt C; Ullmann H; Kassack MU; Nickel P
    Curr Pharm Des; 2002; 8(26):2371-99. PubMed ID: 12369951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P2X purinergic receptor ligands: recently patented compounds.
    Gunosewoyo H; Kassiou M
    Expert Opin Ther Pat; 2010 May; 20(5):625-46. PubMed ID: 20205618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of P2X7 receptors in the hypoxia-induced death of rat retinal neurons.
    Sugiyama T; Oku H; Shibata M; Fukuhara M; Yoshida H; Ikeda T
    Invest Ophthalmol Vis Sci; 2010 Jun; 51(6):3236-43. PubMed ID: 20071682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of P2X(7) receptors induced [(3)H]GABA release from the RBA-2 type-2 astrocyte cell line through a Cl(-)/HCO(3)(-)-dependent mechanism.
    Wang CM; Chang YY; Kuo JS; Sun SH
    Glia; 2002 Jan; 37(1):8-18. PubMed ID: 11746779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A patent review of P2X7 receptor antagonists to treat inflammatory diseases (2018-present).
    Iqbal J; Bano S; Khan IA; Huang Q
    Expert Opin Ther Pat; 2024 Apr; 34(4):263-271. PubMed ID: 38828613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of antagonists to characterize the receptors mediating depolarization of the rat isolated vagus nerve by alpha, beta-methylene adenosine 5'-triphosphate.
    Trezise DJ; Kennedy I; Humphrey PP
    Br J Pharmacol; 1994 May; 112(1):282-8. PubMed ID: 8032652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ca(2+)-dependent reduction of glutamate aspartate transporter GLAST expression in astrocytes by P2X(7) receptor-mediated phosphoinositide 3-kinase signaling.
    Liu YP; Yang CS; Chen MC; Sun SH; Tzeng SF
    J Neurochem; 2010 Apr; 113(1):213-27. PubMed ID: 20070863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional evidence that ATP or a related purine is an inhibitory NANC neurotransmitter in the mouse jejunum: study on the identity of P2X and P2Y purinoceptors involved.
    De Man JG; De Winter BY; Seerden TC; De Schepper HU; Herman AG; Pelckmans PA
    Br J Pharmacol; 2003 Nov; 140(6):1108-16. PubMed ID: 14530212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre- and postsynaptic actions of ATP on neurotransmission in rat submandibular ganglia.
    Smith AB; Hansen MA; Liu DM; Adams DJ
    Neuroscience; 2001; 107(2):283-91. PubMed ID: 11731102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.